While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback